Avanos Medical, Inc. Announces Third Quarter 2020 Results

Go back to Avanos Medical, Inc. Announces Third Quarter 2020 Results

Avanos Medical, Inc. (AVNS) Tops Q3 EPS by 11c, Revenues Beat

November 3, 2020 7:12 AM EST

Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.21, $0.11 better than the analyst estimate of $0.10. Revenue for the quarter came in at $186 million versus the consensus estimate of $165.87 million.

"Thanks to the work of our team and their focus on execution, our momentum continued as we delivered results ahead of our expectations," stated Joe Woody, Avanos' chief executive officer. "Our performance was bolstered by the... More